Table 2

Major and minor complications within 30 days (TAT vs DAT group)

TAT group (n=110)DAT group (n=73)P-valuesOR95% CI
Major complications, n (%)1 (0.9%)6 (8.2%)0.0170.1020.012 to 0.870
 TIA1 (0.9%)3 (4.1%)0.3030.2140.022 to 2.099
 ischemic stroke0 (0%)3 (4.1%)0.0621.0430.994 to 1.094
 Stent thrombosis0 (0%)0 (0%)
 Intracranial bleeding0 (0%)0 (0%)
 Extracranial bleeding0 (0%)0 (0%)
Minor complications, n (%)1 (0.9%)1 (1.4%)>0.9990.6610.041 to 10.73
  • DAT, dual antiplatelet therapy; TAT, triple antiplatelet therapy; TIA, transient ischemic attack.